Supplementary Table S4 from A Therapeutically Targetable NOTCH1–SIRT1–KAT7 Axis in T-cell Leukemia 著者: Olga Lancho (15125854)

主題:

Supplementary Table S2 from A Therapeutically Targetable NOTCH1–SIRT1–KAT7 Axis in T-cell Leukemia 著者: Olga Lancho (15125854)

主題:

Taming the Piers–Rubinsztajn Reaction: Beyond B(C₆F₅)₃ 著者: David R. Wilson (6243272)

主題:

التبليغات القضائية في المحاكم الشرعية الأردنية 著者: Abu Jamea, Nour Adel Ibrahim

全文の入手

التقاضي عن بعد؛ نحو قضاء إداري إلكتروني في المملكة العربية السعودية 著者: Aljazi , Jehad Dhifallah

全文の入手

Biochemical investigation of wild-type and processed RNG2. 著者: Romuald Haase (22339777)

“…<b>(D)</b> Size-exclusion chromatography (SEC) chromatogram of the affinity-purified RNG2-ΔN+CTer variant obtained via Strep-tactin purification. A Coomassie-stained gel of the protein-containing fractions of the SEC is shown on the right. …”

اختلاف المفسرين في لفظتي (الإل) و(الذمة) الواردتين في الآيتين الثامنة والعاشرة من سورة التوبة 著者: Erfidan , Aliye Merve

全文の入手

Identification of TesA as the periplasmic partner of YbbAP. 著者: Martin B. L. McAndrew (22683641)

“…<b>(D)</b> SDS-PAGE gel showing co-purification of YbbAP-TesA as a complex. Underlying data can be found in <a href="http://www.plosbiology.org/article/info:doi/10.1371/journal.pbio.3003427#pbio.3003427.s018" target="_blank">S1 Data</a>–<a href="http://www.plosbiology.org/article/info:doi/10.1371/journal.pbio.3003427#pbio.3003427.s020" target="_blank">S3 Data</a>.…”

التسجيل وأثره في الحماية القانونية للعلامة التجارية: دراسة تحليلية في قانون العلامات التجارية الأردني... 著者: Obeidat, Ibrahim Mohammad

全文の入手

تشدُّد النقاد في جرح الرواة (مفهومه وأسبابه وضوابطه وآثاره) 著者: Al-Wadi, Manal Omar Mohammed

全文の入手

Factors and outcomes associated with acute kidney injury in brain tumor resection patients: insights from a large US database (2010–2019) 著者: Binbin Tian (21738944)

“…We analyzed brain tumor resection admissions from the United States’ National Inpatient Sample database (2010–2019), identifying hospitalizations with and without AKI using International Classification of Diseases, Ninth Revision, Clinical Modification and International Classification of Diseases, Tenth Revision, Clinical Modification codes. …”

Table 1_GLP-1 agonists and exercise: the future of lifestyle prioritization.docx 著者: Roberto Codella (5856173)

“…<p>Recent literature shows that GLP-1 receptor agonists are highly effective for weight loss and improving metabolic and cardiovascular health, often surpassing the results of lifestyle interventions alone, such as exercise and diet modification. However, long-term weight maintenance is more successful when exercise is included, as stopping GLP-1 therapy alone often leads to weight regain, while exercise helps preserve muscle mass and sustain weight loss. …”

المشهور المبني على الضعيف عند المالكية: دراسة تأصيلية - تطبيقية 著者: Abu Aladas, Ibrahim Ahmed

全文の入手

طبيعة التزام طبيب التجميل في قانون المسؤولية الطبية الأردني رقم 25 لسنة 2018 著者: Altarawneh, Hasan Awad Salem

全文の入手

Supplementary Material for: Long-Term Remission of Peritoneal Lymphangiomatosis with Sirolimus Therapy: A Case Report with 8-Year Follow-Up 著者: figshare admin karger (2628495)

“…After failed conservative management including dietary modification, diuretic therapy, and repeated paracenteses, she was started on sirolimus 2 mg/day in August 2016. …”

Generating IAA-regulatable strains of candidate CIA pathway proteins in <i>Toxoplasma gondii.</i> 著者: Evie R. Hodgson (21866946)

“…The PCR screens testing for genetic modifications are shown at the bottom of each panel. …”

Epitope tagging of candidate CIA pathway proteins in <i>Toxoplasma gondii.</i> 著者: Evie R. Hodgson (21866946)

“…The PCR screens testing for genetic modifications are shown at the bottom of each panel. …”

مراتب النساء في الجرح والتعديل في "تقريب التهذيب" 著者: Al-Husban, Kholud

全文の入手

Image 2_Pharmacogenetic variations and clinical implications of actionable CYP2D6/CYP2C19 variants in Central Indian patients with common mental disorders.tif 著者: Santenna Chenchula (14775163)

“…Overall, 7.5% of patients carried CYP2D6 variants and 20.6% carried CYP2C19 variants, for which CPIC guidelines recommend alternative drug selection or dose modification.</p>Discussion<p>This study demonstrates a high prevalence of actionable CYP2D6 and CYP2C19 variants in the Central Indian population, underscoring the need for pharmacogenetic integration in psychiatric prescribing in Indian clinical settings, to enhance treatment efficacy and minimize adverse events.…”

Data Sheet 1_Characterization of Ty21a immunostimulatory effects in the mouse bladder.pdf 著者: Lenka Polak (17777406)

“…Here, we show that increased immune-cell infiltration was neither associated with modification in blood vessel density nor the generation of high endothelial venules, but rather with a transient increase in local vessel permeability, requiring live bacteria. …”